Table 3.
Continuous monitors | Life support | Point-of-care technology |
---|---|---|
Global | (i) Fluid pumps | (i) Blood gas analysis |
(i) Cardiovascular (ECG, ABP, HR, CVP, CCO, and SvO2) | (ii) Mechanical ventilators | (ii) Centrifuges |
(ii) Respiratory oxygenation(SPO2), ventilation (ETCO2 and EIT) |
(iii) Patient warming sources | (iii) Refractometer |
(iii) Core body temperature | (iv) Oxygen delivery | (iv) Microdialysate analysers |
(iv) Neurological monitoring (cEEG) | (v) Suction apparatus | (v) Multiplatelet function |
Regional | (vi) ECMO | (vi) Rotational thromboelastometry |
(i) Tissue oximetry | (vii) RRT | (vii) Fluoroscopy |
(ii) Tissue perfusion | (viii) HFOV | (viii) Surface and intracardiac echocardiography (USCOM and iCATHe) |
(iii) Tissue metabolism | (ix) VADs | (ix) Renal Doppler |
(x) TAH (BiVACOR) | ||
(xi) Inhaled NO therapy |
ECG: electrocardiograph; ABP: arterial blood pressure; HR: heart rate; CVP: continuous venous pressure; CCO: continuous cardiac output; SvO2: mixed venous oxygen saturation; ETCO2: end tidal carbon dioxide partial pressure; EIT: electrical impedance tomography; cEEG: continuous electroencephalogram; ECMO: extracorporeal membrane oxygenation; RRT: renal replacement therapy; HFOV: high frequency oscillatory ventilation; NO: nitric oxide; USCOM: ultrasonic cardiac output monitor; iCATHe: intracatheter echocardiography; VADs: ventricular assist devices; TAH: total artificial heart.